Tuesday, H.C. Wainwright adjusted the price target for Agios Pharma (NASDAQ: AGIO) shares to $56.00, decreasing from the previous target of $61.00.Despite the reduction, the firm maintained a Buy ...

Servier is paying $1.8 billion upfront for the oncology assets, with the total value of the deal potentially rising to $2 billion if Agios’ key pipeline candidate vorasidenib – a dual ...

Investing.com -- Agios Pharmaceuticals Inc. (NASDAQ:AGIO) stock climbed 2% following the announcement of an exclusive agreement with Avanzanite Bioscience B.V. to commercialize and distribute ...

A whole host of activities to help you raise money for life-changing dementia research. Whether you organise your own or join one of ours, there is a fundraising activity for everyone.

Things to do home See all activities on the map On land Events calendar Car & scooter hire Guided tours Cycling & hiking Adrenaline & fun Mind body & soul See more On water Water sports Boat charter ...